Treatment Research Institute Joins Public Health Management Corporation

NEWS RELEASE

July 18, 2017
Contact: Rebecca Devine 215.434.7191 or This email address is being protected from spambots. You need JavaScript enabled to view it.
Treatment Research Institute Joins Public Health Management Corporation

PHILADELPHIAPublic Health Management Corporation (PHMC), a nonprofit public health institute that creates and sustains healthier communities, announced that it merged Treatment Research Institute (TRI), a leading, national nonprofit research, development and policy organization, into its family of programs.

“PHMC is always looking to complement our portfolio of programs and services with strategies that better meet the public health needs of our communities,” said PHMC President & CEO Richard J. Cohen. “TRI merging into PHMC creates great opportunity for the development of research and scientific-based programs that treat substance use disorders and co-occurring mental health issues, a topic of critical importance in light of today’s opioid epidemic.”

TRI has integrated into PHMC’s Research and Evaluation (R&E) Group, which is dedicated to improving the health of communities through applied, community-based research and rigorous program evaluation designed to inform best practices in the public health and education arenas. TRI and PHMC have had a long-standing collaborative relationship involving multiple initiatives.

“PHMC has always approached its work through a health equity lens, with a focus on team-based science and the need for cross-disciplinary perspectives to solve today’s most pressing public health, education and social problems. We are excited to be joined by a team of world-class scientists who have made critical contributions to the substance abuse treatment and policy arena” said Lisa Bond, Managing Director, PHMC’s R&E Group. “There will be greater opportunity to work across the broad PHMC enterprise, as well as directly with health care providers, insurers, criminal justice agencies, treatment providers, schools, government, and families to achieve a shared goal of influencing public awareness and use of evidence-informed responses to substance use disorders.”

TRI’s research agenda remains committed to finding practical, evidence-based approaches to address substance use disorders.

“There is a critical need to incorporate addiction prevention and treatment into the greater health care system – and the ability to accomplish that scope of work will be much greater under the umbrella of PHMC,” said TRI Founder and Board of Directors Chairman, Thomas McLellan. “This merger marks a major milestone in TRI’s 25-year history, and it supports the forward-thinking mission that is needed to further develop and translate research to improve substance use disorder policies and programs.”
This merger further emphasizes PHMC as a leader in championing forward a public health response to the epidemic of substance abuse and misuse.

###

About Public Health Management Corporation
Public Health Management Corporation (PHMC) is a nonprofit public health institute that creates and sustains healthier communities. PHMC uses best practices to improve community health through direct service, partnership, innovation, policy, research, technical assistance and a prepared workforce. PHMC has served the region since 1972. For more information on PHMC, visit www.phmc.org.

About PHMC’s Research & Evaluation Group
The Research & Evaluation Group at Public Health Management Corporation (PHMC) is committed to understanding and eliminating health and education disparities through applied, community-focused research and evaluation. The approach to this work is one that values collaboration and partnership with other research sectors, communities, stakeholders and individuals who share a commitment to addressing health and education inequities. PHMC’s R&E Group strives to build stronger and more equitable public health and education policies, programs, systems and practices. For more information, visit PHMC R&E Group.

About TRI
The Treatment Research Institute (TRI) was founded in 1992 by A. Thomas McLellan, Ph.D., with a core mission to engineer and translate research to improve substance use disorder policies and programs. The research team is deeply committed to finding practical, science-based solutions to addressing an array of addictions-related public health problems. TRI works to drive the kind of transformative change that is so deeply needed in this field. In order to effect the change that is needed, TRI works with families, schools, health care systems, courts and policy-makers to ensure that our research aligns with then needs of those most affected by substance use disorders. TRI has been singularly focused on translating research into action, and bridging the chasm to create impact. For more information, visit Treatment Research Institute.